词条 | Pramiconazole |
释义 | {{unreferenced|date=March 2015}}{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 366890982 | IUPAC_name = 1- | image = Pramiconazole.png | width = | image2 = | width2 = | drug_name = | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | index_label = | index2_label = | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = | ATC_prefix = none | ATC_suffix = | ATC_supplemental = | PubChem2 = 11411233 | PubChem = 3013050 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | UNII_Ref = {{fdacite|changed|FDA}} | UNII = 4SYH0R661F | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 175797 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 2281806 | chemical_formula = | C=35 | H=39 | F=2 | N=7 | O=4 | molecular_weight = 659.725 g/mol | SMILES = CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F | StdInChI_Ref = {{stdinchicite|changed|chemspider}} | StdInChI = 1S/C35H39F2N7O4/c1-25(2)43-17-18-44(34(43)45)29-6-4-27(5-7-29)40-13-15-41(16-14-40)28-8-10-30(11-9-28)46-20-33-47-22-35(48-33,21-42-24-38-23-39-42)31-12-3-26(36)19-32(31)37/h3-12,19,23-25,33H,13-18,20-22H2,1-2H3/t33-,35+/m0/s1 | StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | StdInChIKey = AEKNYBWUEYNWMJ-QWOOXDRHSA-N }} Pramiconazole is a triazole antifungal undergoing research for the treatment of acute skin and mucosal fungal infections. It is developed by Barrier Therapeutics. {{Antifungals}}{{antiinfective-drug-stub}} 9 : Organofluorides|Dioxolanes|Lanosterol 14α-demethylase inhibitors|Phenol ethers|Piperazines|Ureas|Imidazolidinones|Triazole antifungals|Isopropyl compounds |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。